During the past decade, II Department of Nephrology and Hypertension conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "II Department of Nephrology and Hypertension" are "Kidney Biopsy" (1 trials) and "Nephrotic Syndrome" (1 trials). Many other conditions were trialed in "II Department of Nephrology and Hypertension" in a lesser frequency.

Most popular intervention types in "II Department of Nephrology and Hypertension" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Desmopressin" (1 trials), "Furosemide Injection" (1 trials), "Hypertonic saline" (1 trials) and "intravenous infusion NaCl" (1 trials). Other intervention names were less common.

The vast majority of trials in "II Department of Nephrology and Hypertension" are 2 trials for "All" genders.

Currently, there are NaN active trials in "II Department of Nephrology and Hypertension". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in II Department of Nephrology and Hypertension, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in II Department of Nephrology and Hypertension, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".